Dendrobium nobile Lindl ameliorates learning and memory deficits in scopolamine-treated mice

• Published in: Journal of ethnopharmacology 2024-04, Vol.324, p.117416-117416, Article 117416
• Main Authors: Zhang, Qiumei, Li, Yujiao, Fan, Bei, Wang, Fengzhong, Li, Zhi, Pires Dias, Alberto Carlos, Liu, Xinmin, Wang, Qiong
• Format: Article
• Language: English
• Subjects: acetylcholinesterase; Acetylcholinesterase - metabolism; Animals; antagonists; blood serum; brain; choline acetyltransferase; cognition; Dendrobium; Dendrobium nobile; Dendrobium nobile Lindl (DNL); drugs; enzyme-linked immunosorbent assay; glutathione; Glutathione - metabolism; Hippocampus - metabolism; hyperglycemia; Learning and memory; malondialdehyde; Maze Learning; memory; memory disorders; Memory Disorders - chemically induced; Memory Disorders - drug therapy; Mice; Oxidative Stress; Scopolamine; superoxide dismutase; Superoxide Dismutase - metabolism; traditional medicine
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2023.117416

Dendrobium nobile Lindl (DNL), a valued time-honored herb, possesses immune-boosting and age-delaying properties, has been widely used to treat hyperglycemia and neurological diseases, and is probably a potential drug for improving learning and memory. Scopolamine (Scop), an antagonist for muscarinic receptors, potentially impairing intelligence and memory. This investigation aimed to assess the efficacy of DNL in alleviating scopolamine-induced cognitive deficits in mice and its mechanisms. We utilized the open-field test, novel object recognition test (NOR), and Morris water maze test (MWM) to assess the potential of DNL in ameliorating learning and memory dysfunction caused by scopolamine in mice. Enzyme-linked immunosorbent assay (ELISA) was employed to measure Choline acetyltransferase (ChAT) content and Acetylcholinesterase (AChE) activities in the brain, and oxidative stress-related factors in the serum, including Malondialdehyde (MDA), Superoxide dismutase (SOD), and glutathione (GSH) content. Scopolamine injection significantly reduced the discrimination index of mice in the NOR test and impaired their performance in the MWM test, as demonstrated by longer escape latency, fewer target crossings, and less time spent in the target quadrant in the MWM. After 25 days of administration, DNL increased the discrimination index of the scopolamine-treated mice in the NOR test. DNL reduced the escape latency in the MWM test in the model mice. DNL increased the target crossing number and the percentage of time spent in the target quadrant in the MWM test. ELISA experiments indicated that DNL decreased the AChE activities, increased the ChAT activities, and modulated oxidative stress makers (GSH, SOD, and MDA) in scopolamine-induced mice. DNL may improve the learning and memory in mice treated with scopolamine, possibly by modulating oxidative stress and impaired cholinergic function. [Display omitted]